News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
2 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (66)
3 (2)
4 (14)
5 (297)
6 (263)
7 (227)
8 (79)
9 (6)
10 (9)
11 (173)
12 (214)
13 (136)
14 (156)
15 (56)
17 (3)
18 (145)
19 (230)
20 (173)
21 (177)
22 (79)
23 (2)
25 (134)
26 (227)
27 (192)
28 (175)
29 (97)
30 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
25
26
27
28
29
30
Drug Development
Foresee Pharmaceuticals to Present Phase 1/2 Fanconi Anemia Clinical Study Design for its ALDH2 activator FP-045 at the Fanconi Anemia Research Fund 2023 Scientific Symposium
Foresee Pharmaceuticals, announced that the company will present the clinical design of the FP-045 Phase 1/2 clinical Fanconi anemia clinical study currently being initiated, at the Fanconi Anemia Research Fund 2023 Scientific Symposium taking place in Vancouver, BC, Canada from September 28-October 1, 2023.
September 30, 2023
·
4 min read
BioCapital
Danaher Corporation Completes Separation of Veralto Corporation
Danaher Corporation announced that it has completed the separation of its Environmental & Applied Solutions segment, through the spin-off of Veralto Corporation.
September 30, 2023
·
5 min read
